ArticleInternational journal of cardiology. Cardiovascular risk and prevention2025
Predictive value of serum myeloperoxidase (MPO) concentration combined with triglyceride-glucose index (TyG) for major adverse cardiaovascular events (MACE) in patients with coronary heart disease.
Article in International journal of cardiology. Cardiovascular risk and prevention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronary heart disease (CHD) remains a leading cause of mortality globally. The prognostic value of myeloperoxidase (MPO) and the triglyceride-glucose (TyG) index in predicting adverse cardiovascular events among individuals with CHD remains uncertain. This study aimed to investigate the predictive value of MPO in combination with the TyG index for major adverse cardiovascular events (MACE) in patients with CHD. Method: A total of 731 patients with CHD admitted to the First Affiliated Hospital of Xinjiang Medical University between July 2022 and January 2024 were enrolled and analyzed. Patients were categorized based on median values of MPO and the TyG index. Subsequent follow-up was conducted to determine the occurrence of MACE within two years of hospital discharge. Multivariate logistic regression analysis was performed to assess the associations between MPO, the TyG index, and MACE. The area under the receiver operating characteristic (ROC) curve (AUC) was utilized to identify the most valuable predictor. Kaplan-Meier curve analysis was employed to examine the relationship between the predictor and prognosis. Results: 263 patients experienced MACE during a median follow-up of two years. Compared to patients with a lower TyG index (<8.44) and MPO (<417 ng/ml), those with a higher combined TyG index and MPO exhibited the highest risk of MACE. Multivariate logistic regression analysis demonstrated that both the TyG index and MPO level were significant predictors of MACE ( Conclusion: The TyG index and MPO exhibit a synergistic interaction in increasing the risk of MACE in patients with CHD. These findings underscore the importance of utilizing both measures concurrently when assessing cardiovascular risk in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.